The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: Dominance of innate immune responses in psoriasis

American Journal of Pathology

Volumn 171, Issue 1, 2007, Pages 32-42

  Mee, John B ^a,d   Johnson, Claire M ^b   Morar, Nilesh ^c   Burslem, Frank ^b   Groves, Richard W ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1ALPHA; TRANSCRIPTOME; INTERLEUKIN 1;

ADAPTIVE IMMUNITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA REPLICATION; DRUG ACTIVITY; GENETIC TRANSCRIPTION; HISTOCOMPATIBILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; KERATINOCYTE; MICROARRAY ANALYSIS; MICROENVIRONMENT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PSORIASIS; SKIN BIOPSY; UPREGULATION; CELL CULTURE; COMPARATIVE STUDY; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; NUCLEIC ACID HYBRIDIZATION;

CELLS, CULTURED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, NATURAL; INTERFERON TYPE II; INTERLEUKIN-1; KERATINOCYTES; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PSORIASIS; TRANSCRIPTION, GENETIC;

EID: 34547671041     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.061067     Document Type: Article

References (49)

1. Schön MP, Boehncke WH: Psoriasis. N Engl J Med 2005, 352:1899-1912
2. Austin LM, Ozawa M, Kikuchi T, Walters IB, Krueger JG: The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-γ, interleukin-2, and tumor necrosis factor-α, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 1999, 113:752-759
3. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ: The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 1993, 101:701-705
4. Wrone-Smith T, Nickoloff BJ: Dermal injection of immunocytes induces psoriasis. J Clin Invest 1996, 98:1878-1887
5. Griffiths CE: T-cell-targeted biologicals for psoriasis. Curr Drug Targets Inflamm Allergy 2004, 3:157-161
6. Kupper TS, Fuhlbrigge RC: Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol 2004, 4:211-222
7. Barker JN, Mitra RS, Griffiths CE, Dixit VM, Nickoloff BJ: Keratinocytes as initiators of inflammation. Lancet 1991, 337:211-214
8. Kupper TS, Groves RW: The interleukin-1 axis and cutaneous inflammation. J Invest Dermatol 1995, 105:62S-66S
9. Bos JD, de Rie MA, Teunissen MB, Piskin G: Psoriasis: dysregulation of innate immunity. Br J Dermatol 2005, 152:1098-1107
10. Nickoloff BJ: Skin innate immune system in psoriasis: friend or foe? J Clin Invest 1999, 104:1161-1164
11. Carroll JM, Romero MR, Watt FM: Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell 1995, 83:957-968
12. Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K, Itami S, Nickoloff BJ, DiGiovanni J: Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 2005, 11:43-49
13. Pasparakis M, Courtois G, Hafner M, Schmidt-Supprian M, Nenci A, Toksoy A, Krampert M, Goebeler M, Gillitzer R, Israel A, Krieg T, Rajewsky K, Haase I: TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 2002, 417:861-866
14. Zenz R, Eferl R, Kenner L, Florin L, Hummerich L, Mehic D, Scheuch H, Angel P, Tschachler E, Wagner EF: Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 2005, 437:369-375
15. Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, Boyman O, Burg G, Liu YJ, Gilliet M: Plasmacytoid predendritio cells initiate psoriasis through interferon-α production. J Exp Med 2005, 202:135-143
16. Bowcock AM, Shannon W, Du F, Duncan J, Cao K, Aftergut K, Catier J, Fernandez-Vina MA, Menter A: Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet 2001, 10:1793-1805
17. Nomura I, Gao B, Boguniewicz M, Darst MA, Travers JB, Leung DY: Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 2003, 112:1195-1202
18. Quekenborn-Trinquet V, Fogel P, Aldana-Jammayrac O, Ancian P, Demarchez M, Rossio P, Richards HL, Kirby B, Nguyen C, Voegel JJ, Griffiths CE: Gene expression profiles in psoriasis: analysis of impact of body site location and clinical severity. Br J Dermatol 2005, 152:489-504
19. Zhou X, Krueger JG, Kao MC, Lee E, Du F, Menter A, Wong WH, Bowcock AM: Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63, 100-element oligonucleotide array. Physiol Genomics 2003, 13:69-78
20. Mee JB, Alam Y, Groves RW: Human keratinocytes constitutively produce but do not process interleukin-18. Br J Dermatol 2000, 143:330-336
21. Hardas BD, Zhao X, Zhang J, Longqing X, Stoll S, Elder JT: Assignment of psoriasin to human chromosomal band 1q21: coordinate overexpression of clustered genes in psoriasis. J Invest Dermatol 1996, 106:753-758
22. Leigh IM, Navsaria H, Purkis PE, McKay IA, Bowden PE, Riddle PN: Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. Br J Dermatol 1995, 133:501-511
23. Capon F, Semprini S, Chimenti S, Fabrizi G, Zambruno G, Murgia S, Carcassi C, Fazio M, Mingarelli R, Dallapiccola B, Novelli G: Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21. J Invest Dermatol 2001, 116:728-730
24. Cooper KD, Hammerberg C, Baadsgaard O, Elder JT, Chan LS, Taylor RS, Voorhees JJ, Fisher G: Interleukin-1 in human skin: dysregulation in psoriasis. J Invest Dermatol 1990, 95:24S-26S
25. Debets R, Hegmans JP, Croughs P, Troost RJ, Prins JB, Benner R, Prens EP: The IL-1 system in psoriatic skin: iL-1 antagonist sphere of influence in lesional psoriatic epidermis. J Immunol 1997, 158:2955-2963
26. Debets R, Timans JC, Homey B, Zurawski S, Sana TR, Lo S, Wagner J, Edwards G, Clifford T, Menon S, Bazan JF, Kastelein RA: Two novel IL-1 family members, IL-1δ and IL-1ε, function as an antagonist and agonist of NF-κB activation through the orphan IL-1 receptor-related protein 2. J Immunol 2001, 167:1440-1446
27. Mee JB, Cork MJ, di Giovine FS, Duff GW, Groves RW: Interleukin-1: a key inflammatory mediator in psoriasis? Cytokine 2006, 33:72-78
28. Cooper KD, Hammerberg C, Baadsgaard O, Elder JT, Chan LS, Sauder DN, Voorhees JJ, Fisher G: IL-1 activity is reduced in psoriatic skin: decreased IL-1α and increased nonfunctional IL-1β. J Immunol 1990, 144:4593-4603
29. Mee JB, Antonopoulos C, Poole S, Kupper TS, Groves RW: Counter-regulation of interleukin-1α (IL-1α) and IL-1 receptor antagonist in murine keratinocytes. J Invest Dermatol 2005, 124:1267-1274
30. Rae MT, Niven D, Ross A, Forster T, Lathe R, Critchley HO, Ghazal P, Hillier SG: Steroid signalling in human ovarian surface epithelial cells: the response to interleukin-1α determined by microarray analysis. J Endocrinol 2004, 183:19-28
31. Towne JE, Garka KE, Renshaw BR, Virca GD, Sims JE: Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-κB and MAPKs. J Biol Chem 2004, 279:13677-13688
32. Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA: Interleukin-32: a cytokine and inducer of TNFα. Immunity 2005, 22:131-142
33. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone DL, Ma A, Koonin EV, Dixit VM: Deubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 2004, 430:694-699
34. Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD: Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture: cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. J Clin Invest 1995, 95:317-327
35. Boyman O, Hefti HP, Conrad C, Nickoloff BJ, Suter M, Nestle FO: Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-α. J Exp Med 2004, 199:731-736
36. Flier J, Boorsma DM, van Beek PJ, Nieboer C, Stoof TJ, Willemze R, Tensen CP: Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol 2001, 194:398-405
37. Banno T, Adachi M, Mukkamala L, Blumenberg M: Unique keratinocyte- specific effects of interferon-gamma that protect skin from viruses, identified using transcriptional profiling. Antivir Ther 2003, 8:541-554
38. Banno T, Gazel A, Blumenberg M: Effects of tumor necrosis factor-α (TNF α) in epidermal keratinocytes revealed using global transcriptional profiling. J Biol Chem 2004, 279:32633-32642
39. Shi J, Schmitt-Talbot E, DiMattia DA, Dullea RG: The differential effects of IL-1 and TNF-α on proinflammatory cytokine and matrix metalloproteinase expression in human chondrosarcoma cells. Inflamm Res 2004, 53:377-389
40. Wei L, Debets R, Hegmans JJ, Benner R, Prens EP: IL-1β and IFN-γ induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system: IFN-γ up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production. J Pathol 1999, 187:358-364
41. Sesto A, Navarro M, Burslem F, Jorcano JL: Analysis of the ultraviolet B response in primary human keratinocytes using oligonucleotide microarrays. Proc Natl Acad Sci USA 2002, 99:2965-2970
42. Cooper L, Johnson C, Burslem F, Martin P: Wound healing and inflammation genes revealed by array analysis of "macrophageless" PU.1 null mice. Genome Biol 2005, 6:R5.1-R5.17
43. Groves RW, Mizutani H, Kieffer JD, Kupper TS: Inflammatory skin disease in transgenic mice that express high levels of interleukin 1α in basal epidermis. Proc Natl Acad Sci USA 1995, 92:11874-11878
44. Shepherd J, Little MC, Nicklin MJ: Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist. J Invest Dermatol 2004, 122:665-669
45. Glaser R, Harder J, Lange H, Bartels J, Christophers E, Schroder JM: Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 2005, 6:57-64
46. de Jongh GJ, Zeeuwen PL, Kucharekova M, Pfundt R, van der Valk PG, Blokx W, Dogan A, Hiemstra PS, van de Kerkhof PC, Schalkwijk J: High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol 2005, 125:1163-1173
47. Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, Darst MA, Gao B, Boguniewicz M, Travers JB, Leung DY: Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003, 171:3262-3269
48. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, Fouser LA: Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006, 203:2271-2279
49. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240